SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-21-001090
Filing Date
2021-06-24
Accepted
2021-06-24 16:21:28
Documents
18
Period of Report
2021-06-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e2871_8-k.htm   iXBRL 8-K 27188
2 EXHIBIT 5.1 e2871_ex5-1.htm EX-5.1 10437
3 EXHIBIT 10.1 e2871_ex10-1.htm EX-10.1 45124
4 EXHIBIT 10.2 e2871_ex10-2.htm EX-10.2 203653
5 EXHIBIT 99.1 e2871_ex99-1.htm EX-99.1 9942
6 GRAPHIC ex10-1_001.jpg GRAPHIC 26104
7 GRAPHIC ex5-1_001.jpg GRAPHIC 10605
  Complete submission text file 0001731122-21-001090.txt   591952

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE avxl-20210622.xsd EX-101.SCH 3017
9 XBRL LABEL FILE avxl-20210622_lab.xml EX-101.LAB 34238
10 XBRL PRESENTATION FILE avxl-20210622_pre.xml EX-101.PRE 22353
11 EXTRACTED XBRL INSTANCE DOCUMENT e2871_8-k_htm.xml XML 3701
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 211043079
SIC: 8731 Services-Commercial Physical & Biological Research